|
A new Report on "The Uptake and Diffusion of Health Related Biotechnologies" will be available in 2010. The Report identifies the range of incentives and barriers that are affecting the uptake and into the health care sector of health biotechnologies which differ in their stage of development, from innovations that are relatively mature to those that are still very new on the market. The case studies include: monoclonal antibodies as diagnostics and as therapeutics; genetic testing DNA micro-arrays; and a drug delivery technology illustrating the convergence of bio- and nano-technologies.
For each technology, the report identifies its clinical utility and factors stimulating and/or inhibiting its diffusion. The report makes clear that institutional frameworks and technology co-evolve, and that even when breakthroughs occur diffusion cannot be expected if the necessary institutional adjustments are not made. A striking finding is that in many cases the technology itself has progressed far faster than the institutional mechanisms that are needed support widespread diffusion and uptake.
Forthcoming Publication
The Uptake and Diffusion of Health Related Biotechnologies: Case Studies.
|
